Intercept Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
ICPT
CUSIP
45845P108
All holders as of
Q3 2023
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2023 Q3 172 39.1 M $726 M
2023 Q2 145 35.0 M $387 M
2023 Q1 157 28.6 M $384 M
2022 Q4 163 31.7 M $392 M
2022 Q3 180 28.9 M $402 M
2022 Q2 166 24.3 M $336 M
2022 Q1 167 24.4 M $397 M
2021 Q4 182 24.8 M $404 M
2021 Q3 164 22.3 M $331 M
2021 Q2 150 22.3 M $445 M
2021 Q1 178 24.6 M $569 M
2020 Q4 210 26.9 M $665 M
2020 Q3 209 28.4 M $1.18 B
2020 Q2 230 26.8 M $1.28 B
2020 Q1 227 25.4 M $1.60 B
2019 Q4 262 26.2 M $3.25 B
2019 Q3 226 26.3 M $1.74 B
2019 Q2 235 27.3 M $2.17 B
2019 Q1 249 23.0 M $2.58 B
2018 Q4 221 21.1 M $2.13 B
2018 Q3 219 20.7 M $2.62 B
2018 Q2 191 21.2 M $1.77 B
2018 Q1 171 19.9 M $1.23 B
2017 Q4 196 18.5 M $1.08 B
2017 Q3 191 18.5 M $1.08 B
2017 Q2 192 20.6 M $2.50 B
2017 Q1 177 21.1 M $2.38 B
2016 Q4 201 20.9 M $2.27 B
2016 Q3 206 20.6 M $3.38 B
2016 Q2 204 20.4 M $2.91 B
2016 Q1 189 18.8 M $2.42 B
2015 Q4 196 18.7 M $2.79 B
2015 Q3 194 18.6 M $3.09 B
2015 Q2 212 18.1 M $4.36 B
2015 Q1 222 17.8 M $5.01 B
2014 Q4 194 15.7 M $2.45 B
2014 Q3 200 12.9 M $3.06 B
2014 Q2 192 13.4 M $3.18 B
2014 Q1 191 12.5 M $4.11 B